U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478458) titled 'ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder' on Aug. 05, 2025.
Brief Summary: This study aims to evaluate a new driving simulator, called ADRIS 2.1, developed for adolescents aged 13-18 years with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common neurodevelopmental disorder that can affect attention, self-control, and decision-making. These challenges may impact daily activities, including driving.
The ADRIS simulator allows participants to "drive" in a virtual environment while their performance is monitored. The system measures driving errors (such as not stopping at ...